• FAD patients with PSEN1 mutations were more likely to have significant headaches, myoclonus, gait abnormality, and pseudobulbar affect. • Differences in pathophysiology between FAD and NF-EAD and findings in some contexts should lead to genetic counseling and appropriate recommendations for genetic testing for FAD. The gene discussed is PSEN1; the disease is familial Alzheimer disease.